Attached files
file | filename |
---|---|
10-K - Rackwise, Inc. | v211438_10k.htm |
EX-21 - Rackwise, Inc. | v211438_ex21.htm |
EX-31.1 - Rackwise, Inc. | v211438_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Cahaba Pharmaceuticals, Inc. (the
“Company”) on Form 10-K for the fiscal year ended October 31, 2010 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Kenneth Spiegeland, Chief Executive Officer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
Date: February
14, 2011
|
/s/ Kenneth
Spiegeland
|
|||
|
Kenneth
Spiegeland
|
|||
|
Chief
Executive Officer
and
Chief Financial Officer
|